Stephan Baldus and Dr. C Michael Gibson Discuss: MATTERHORN: Atrial MR SubgroupTranscatheter Repair Versus Surgery in Atrial Mitral Regurgitation: Results From the MATTERHORN Trial October 30, 2024 Disclosures: TBD
Firas Zahr and Dr. C Michael Gibson Discuss: CLASP IID 2 YearRCT and Registry: Two-Year Outcomes of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation October 30, 2024 Disclosures: TBD
Olivier F Bertrand and Dr. C Michael Gibson Discuss: TARGET IVInternational Multicenter Randomized Assessment of the Firehawk® Rapamycin Eluting Coronary Stent System October 30, 2024 Disclosures: TBD
Birgitte Krogsgaard Andersen and Niels Ramsing Holm and Dr. C Michael Gibson Discuss: FAVOR III EuropeQuantitative Flow Ratio or Fractional Flow Reserve for Guiding Coronary Revascularization October 30, 2024 Disclosures: TBD
Expert Roundtable – Vulnerable Plaque, Past, Present and Future October 30, 2024 Disclosure: Sponsored by Cleerly Health
Sanjit S. Jolly and Dr. C Michael Gibson Discuss: CLEAR SYNERGY (OASIS 9)A 2×2 Factorial Randomized Controlled Trial of Colchicine Versus Placebo and Spironolactone Versus Placebo in Patients With Myocardial Infarction: The Results of the Colchicine Factorial October 29, 2024 Disclosures: TBD
Ajay J. Kirtane and Dr. C Michael Gibson Discuss: ECLIPSEA Large-Scale, Randomized Trial of Orbital Atherectomy vs. Conventional Balloon Angioplasty in Severely Calcified Coronary Arteries Prior to DES Implantation October 29, 2024 Disclosures: TBD
Alexander Van Rosendael and Dr. C Michael Gibson Discuss: CONFIRM-2Artificial Intelligence Enabled Quantitative CT Assessment of Atherosclerosis and Major Adverse Events: A Multi-Center International Registry October 28, 2024 Disclosures: TBD
David Erlinge and Dr. C Michael Gibson Discuss: INFINITY-SWEDEHEART Complex PCI1-Year and Landmark 6–12 Month Clinical Outcomes Among Patients With Complex Lesion Subsets Treated with DynamX Bioadaptor Compared to a Contemporary Drug Eluting Stent October 28, 2024 Disclosures: TBD
Marc Dweck and Dr. C Michael Gibson Discuss: EVOLVEDEarly Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis October 28, 2024 Disclosures: TBD
